AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis	Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis	Not yet recruiting	Not applicable	2026-09-30		NCT07619638

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Aydin Adnan Menderes University	57
Dokuz Eylul University	45
Ege University Medical School	2
ENBIOSIS BIOTECHNOLOGIES	2
Tepecik Training and Research Hospital	6

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ege University	Izmir	Turkey (Türkiye)	5